Canada: No uptick in trauma patients testing positive for cannabis after legalization

The enactment of adult-use marijuana legalization is not associated with any immediate uptick in the percentage of trauma patients testing positive for past cannabis exposure, according to data published in the Canadian Journal of Surgery.  A team of researchers with Western University in London, Ontario evaluated adults admitted into a leading Canadian trauma center in the three months … Continue reading Canada: No uptick in trauma patients testing positive for cannabis after legalization

NIH refuses Senate request for information on gain of function research

TU.S. Sen. Ron Johnson (R-Wis.) joined by Sens. Paul (R-Ky.), Lankford (R-Okla.), Scott (R-Fla.), Cotton (R-Ark.), Marshall (R-Kan.), and Rep. Mike Gallagher (R-Wis.) sent a follow up letter to Dr. Francis Collins, Director of the National Institutes of Health (NIH) requesting further information on gain of function research and NIH’s 2014 moratorium on funding for that research. This letter follows NIH’s incomplete response to their May 20 letter, the lawmakers point out the agency’s refusal to provide a detailed response is unacceptable and that the American people deserve the complete truth about NIH’s role in funding potentially risky gain of function research.

Cannabis associated with improvements in patient with treatment resistant stuttering

Following the daily administration of vaporized plant cannabis, the patient exhibited sustained improvements in speech fluency and also reported benefits to his overall quality of life. The patient did not report any adverse side effects from cannabis over the one-year observational period.